Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 2.89T | 2.73T | 2.41T | 1.98T | 1.76T |
Gross Profit | 1.03T | 964.48B | 636.22B | 299.43B | -40.26B |
EBITDA | 778.32B | 748.45B | 541.16B | 274.28B | -120.36B |
Net Income | 224.28B | 196.45B | 99.23B | -94.95B | -577.90B |
Balance Sheet | |||||
Total Assets | 10.17T | 9.77T | 9.41T | 9.16T | 8.98T |
Cash, Cash Equivalents and Short-Term Investments | 233.67B | 281.00B | 215.19B | 171.29B | 198.27B |
Total Debt | 4.65T | 4.56T | 4.79T | 4.72T | 4.37T |
Total Liabilities | 7.30T | 7.03T | 6.91T | 6.74T | 6.42T |
Stockholders Equity | 2.86T | 2.72T | 2.47T | 2.39T | 2.54T |
Cash Flow | |||||
Free Cash Flow | -38.68B | -26.81B | 26.17B | -392.55B | -955.45B |
Operating Cash Flow | 732.25B | 688.10B | 581.75B | 190.51B | -189.97B |
Investing Cash Flow | -783.42B | -690.62B | -565.51B | -526.36B | -749.40B |
Financing Cash Flow | 3.66B | 66.10B | 26.83B | 304.64B | 983.38B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $21.84B | 7.49 | 16.87% | 0.86% | 3.24% | 4.46% | |
79 Outperform | $62.07B | 18.74 | 24.11% | 1.94% | 0.71% | 86.84% | |
78 Outperform | $132.09B | 19.40 | 42.35% | 2.43% | 1.06% | 8.13% | |
76 Outperform | $60.42B | 19.92 | 24.83% | 1.56% | -3.27% | -10.73% | |
71 Outperform | $27.14B | 17.54 | 8.29% | 0.97% | 4.26% | 78.25% | |
64 Neutral | $10.96B | 16.35 | 8.89% | 1.96% | 2.68% | -15.17% | |
63 Neutral | $17.54B | 50.23 | 4.30% | 2.18% | 1.64% | 284.24% |